Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/16/23 08:51 | 2/15/23 | CNCE | Health | Drug | Pharmaceutical Preparations | Stuart Nancy | MA | O | COO | S | -50 | 8.33 | 0 | -6 | -2 | 263 | D | ||||||||||||||
2/16/23 08:49 | 2/15/23 | CNCE | Health | Drug | Pharmaceutical Preparations | Munsie Jeffrey A | MA | O | GC | S | -31 | 8.34 | 0 | -4 | -4 | 88 | D | ||||||||||||||
2/16/23 08:48 | 2/15/23 | CNCE | Health | Drug | Pharmaceutical Preparations | Cassella James V | MA | O | Chief De | S | -31 | 8.34 | 0 | -4 | -2 | 173 | D | ||||||||||||||
2/16/23 08:47 | 2/15/23 | CNCE | Health | Drug | Pharmaceutical Preparations | Becker Marc A. | MA | O | CFO | S | -31 | 8.33 | 0 | -4 | -3 | 124 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |